T
Thumzup Media Corp
OTC:TZUP
Thumzup Media Corp
OTC:TZUP
Price:
3.375
USD
-18.08%
Market Closed
Market Cap:
$55.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Thumzup Media Corp
OTC:TZUP
|
US |
|
Riverine China Holdings Ltd
HKEX:1417
|
CN |
|
P
|
Pharmala Biotech Holdings Inc
CNSX:MDMA
|
CA |
|
H
|
Huntwicke Capital Group Inc
OTC:HCGI
|
US |
|
V
|
Veolia Environnement SA
SWB:VVD
|
FR |
|
C
|
Crown Holdings Inc
LSE:0I4X
|
US |
|
S
|
Sanofi SA
XMUN:SNW
|
FR |
|
C
|
Callan JMB Inc
NASDAQ:CJMB
|
US |
|
KMD Brands Ltd
OTC:KTHUF
|
NZ |
Income Statement
Earnings Waterfall
Thumzup Media Corp
Thumzup Media Corp
Income Statement
Thumzup Media Corp
Thumzup Media Corp
Currency: USD
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
+24%
|
0
+23%
|
0
-73%
|
0
+200%
|
0
-11%
|
0
-25%
|
0
-56%
|
0
+48%
|
0
-16%
|
0
N/A
|
0
-73%
|
0
-29%
|
0
N/A
|
0
+40%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
+70%
|
0
+15%
|
0
+10%
|
0
-56%
|
0
+58%
|
0
-20%
|
0
+4%
|
0
-72%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(17)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(16)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(1)
N/A
|
(1)
-15%
|
(1)
0%
|
(1)
-9%
|
(2)
-106%
|
(3)
-18%
|
(3)
-15%
|
(3)
+25%
|
(4)
-70%
|
(4)
+4%
|
(4)
+7%
|
(4)
-3%
|
(5)
-36%
|
(6)
-21%
|
(17)
-157%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Other Income |
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(1)
-15%
|
(1)
+0%
|
(2)
-34%
|
(3)
-98%
|
(4)
-22%
|
(4)
-23%
|
(3)
+25%
|
(6)
-71%
|
(5)
+7%
|
(5)
+13%
|
(4)
+13%
|
(6)
-45%
|
(6)
-11%
|
(16)
-155%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(6)
|
(5)
|
(5)
|
(4)
|
(6)
|
(6)
|
(16)
|
|
| Net Income (Common) |
(1)
N/A
|
(1)
-15%
|
(1)
+0%
|
(2)
-34%
|
(3)
-98%
|
(4)
-22%
|
(4)
-23%
|
(3)
+25%
|
(6)
-71%
|
(5)
+7%
|
(5)
+12%
|
(4)
+14%
|
(6)
-46%
|
(6)
-11%
|
(16)
-154%
|
|
| EPS (Diluted) |
-0.16
N/A
|
-0.18
-12%
|
-0.18
N/A
|
-0.24
-33%
|
-0.41
-71%
|
-0.51
-24%
|
-0.6
-18%
|
-0.47
+22%
|
-0.74
-57%
|
-0.68
+8%
|
-0.6
+12%
|
-0.5
+17%
|
-0.61
-22%
|
-0.67
-10%
|
-1.2
-79%
|
|
Switch to:
Switch to:
See Also
Discover More
